Abstract

407P Palbociclib plus endocrine therapy in HR+/HER2- advanced breast cancer patients: Interim results of the PERFORM study

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Time to treatment failure (TTF) and overall survival (OS) with palbociclib (PAL) plus endocrine therapy (ET) versus ET in HR+/HER2- advanced breast cancer (ABC) patients: A real-world multicenter study from China.
Lanxin Zhang ... Hongliang Zhang
Journal of Clinical Oncology | VOL. 41
Lanxin Zhang, et. al.Lanxin Zhang ... Hongliang Zhang
01 Jun 2023
Efficacy and Safety of CDK4/6 Inhibitors Combined with Endocrine Therapy in HR+/HER-2− ABC Patients: A Systematic Review and Meta-Analysis
Yongyan Li ... Qin Li
Cancer Investigation | VOL. 39
Yongyan Li, et. al.Yongyan Li ... Qin Li
22 Apr 2021
Abstract PO4-16-07: Cyclin-dependent kinase inhibitor plus endocrine therapy in HR+/HER2- invasive breast cancer with bone marrow and pancytopenia: a new standard of care? Collaborative multicentric Argentinean real-world study (SUMA-02)
Alexis Ostinelli ... Jorge Nadal
American Journal of Cancer | VOL. 84
Alexis Ostinelli, et. al.Alexis Ostinelli ... Jorge Nadal
02 May 2024
The Effect of P-Glycoprotein (P-gp), Nuclear Factor-Kappa B (Nf-κb), and Aldehyde Dehydrogenase-1 (ALDH-1) Expression on Metastases, Recurrence and Survival in Advanced Breast Cancer Patients
Yan Wisnu Prajoko ... Teguh Aryandono
Asian Pacific journal of cancer prevention : APJCP | VOL. 20
Yan Wisnu Prajoko, et. al.Yan Wisnu Prajoko ... Teguh Aryandono
01 May 2019
View more papers

More From: Annals of oncology : official journal of the European Society for Medical Oncology

Paper Title
Journal
Date
Author
Neratinib and ado-trastuzumab emtansine for pretreated and untreated human epidermal growth factor receptor 2 (HER2)-positive breast cancer brain metastases: Translational Breast Cancer Research Consortium trial 022
R.A Freedman ... N.U Lin
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. -
R.A Freedman, et. al.R.A Freedman ... N.U Lin
06 Jul 2024
Primary tumor resection for asymptomatic colorectal cancer with unresectable metastasis: the end of the dilemma
Sebastiano Biondo ... Esther Kreisler
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. -
Sebastiano Biondo, et. al.Sebastiano Biondo ... Esther Kreisler
03 Jul 2024
Challenging immune exhaustion in early recurrent triple-negative breast cancer: pitfalls and hopes
P Tarantino ... S M Tolaney
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 35
P Tarantino, et. al.P Tarantino ... S M Tolaney
01 Jul 2024
Elevating Cancer on the Global Health Agenda: Towards the 4th High-Level Meeting on NCDs 2025
Raffaella Casolino ... Andrè Ilbawi
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. -
Raffaella Casolino, et. al.Raffaella Casolino ... Andrè Ilbawi
01 Jul 2024
View more papers